✦ LIBER ✦

Perilymphatic injections of recombinant interleukin-2 (rIL-2) partially correct the immunologic defects in patients with advanced head and neck squamous cell carcinoma

✍ Scribed by Giovanni Melioli; Giovanni Margarino; Marco Scala; Paola Mereu; Sergio Bertoglio; Guido Schenone; Maurizio Barbaresi; Anna Maria Machi; Leonardo Santi; Fausto Badellino; Lorenzo Moretta

Book ID: 115043876
Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 635 KB
Volume: 102
Category: Article
ISSN: 0023-852X
DOI: 10.1288/00005537-199205000-00018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intensive recombinant interleukin-2 and

Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma

✍ Susan G. Urba; Arlene A. Forastiere; Gregory T. Wolf; Philip C. Amrein 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Immune restoration with interleukin-2 in

Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck

✍ Harold J. Wanebo; Tim Jones; Ronald Pace; Robert Cantrell; Paul Levine 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 586 KB

Improved survival with perilymphatic int

Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx

✍ Antonella De Stefani; Guido Forni; Riccardo Ragona; Giovanni Cavallo; Mario Buss 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

## Abstract ## BACKGROUND The current randomized, multicenter, Phase III trial was conducted to determine whether the disease free interval and overall survival of patients with T2–T4,N0–N3,M0 squamous cell carcinoma (SCC) of the oral cavity or oropharynx could be extended through the combination

A trial of IRX-2 in patients with squamo

A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck

✍ J Hadden; E Verastegui; J.L Barrera; M Kurman; A Meneses; J.W Zinser; J de la Ga 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 419 KB

Neo-adjuvant chemo-(immuno-) therapy of

Neo-adjuvant chemo-(immuno-) therapy of advanced head and neck squamous cell carcinoma (HNSCC): A multicenter phase III randomized study comparing cisplatin (CDDP) + 5-FU with CDDP + 5-FU + recombinant interleukin 2 (rIL 2): Preliminary results

✍ G. Mantovani; M. Airoldi; A. Bianchi; M. Ghiani; G. Succu; D. Massa; L. Curreli; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Incomplete Th2 skewing of cytokines in p

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

✍ Deanne M.R Lathers; Nicholas J Achille; M.Rita I Young 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 303 KB